<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Pharmacy</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/65B021C4-5B6A-4A1D-BF47-D1FCBE05D3C2"><gtr:id>65B021C4-5B6A-4A1D-BF47-D1FCBE05D3C2</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>Lucy</gtr:otherNames><gtr:surname>Jopling</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF02360X%2F1"><gtr:id>1199B1B0-8B95-49D5-A47F-5B7DED25B2BC</gtr:id><gtr:title>MicroRNA-mediated regulation of viral replication</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/F02360X/1</gtr:grantReference><gtr:abstractText>Genes are long sections of DNA that are copied into long molecules of a similar substance, RNA. These messenger RNAs are interpreted by machines known as ribosomes to make proteins, which carry out the functions in our cells. Recently, it was found that some genes are copied to make very short sequences of RNA, known as microRNAs. MicroRNAs are not used to make protein themselves, but instead bind to messenger RNA molecules that have a matching sequence for the microRNA. This binding leads to a reduction in the amount of protein made from that messenger RNA, and so is important in controlling the levels of particular proteins present in a cell, and therefore the behaviour of the cell. The hepatitis C virus (HCV) genome is composed of a long strand of RNA, which enters liver cells where it is used as a template to make HCV proteins. These make more copies of the HCV RNA, a process known as viral replication. I recently found that miR-122, a microRNA that is only found in the liver, binds to a site in HCV RNA. This binding is needed for viral replication to occur. This positive effect on viral replication is very different to the negative effects on protein synthesis that miRNAs normally promote. Interestingly, if the miR-122 binding site from HCV is moved to a different place in a different gene, it acts to repress protein synthesis. The aim of this research is to understand how a microRNA can mediate two such different processes. As the location of the binding site is important for its function, versions of HCV will be made with sites in different locations and tested to see what the requirements for the site are. Proteins are known to be important for microRNAs to function, so proteins that bind to miR-122 while it interacts with HCV RNA will be detected. These will be compared to the proteins used by microRNAs to repress protein synthesis. Finally, experiments will be carried out to detect when in the HCV replication cycle miR-122 interacts. Together, these experiments will help to explain how miR-122 is able to regulate HCV replication. This research will be carried out in the RNA biology group in the new Centre for Biomolecular Sciences at the University of Nottingham. Researchers in the group work on several different aspects of RNA, and are based in state-of-the-art new laboratories with all the necessary facilities for RNA research.</gtr:abstractText><gtr:technicalSummary>The liver-specific microRNA-122 (miR-122) binds to a site close to the 5' end of hepatitis C virus (HCV) RNA and is essential for replication of the virus. miRNAs had previously been shown to act by binding to the 3' untranslated regions (UTRs) of target mRNAs and repressing gene expression. The miR-122 site from HCV acts to repress translation when inserted in the 3' UTR of a luciferase mRNA. Moreover, it was recently shown that several miRNAs bind to HCV RNA and repress gene expression. Therefore, it appears that the location of the miR-122 binding site in HCV is crucial in determining its function. In order to understand how a miRNA can mediate such different events, the mechanism by which miR-122 regulates HCV replication will be analysed and compared to miRNA-dependent repression of translation. 1. The requirements for location and context of the miR-122 binding site will be determined by mutational analysis, both in HCV and in the luciferase reporter construct in which miR-122 represses translation. This will allow comparison of the requirements for the two processes. 2. The protein factor requirements for the two processes mediated by miR-122 will be compared. A streptavidin affinity purification system will be used to detect proteins that interact with biotinylated miR-122 in complex with HCV RNA. Known and novel interacting proteins will be identified by western blotting and sequencing. RNAi will be used to determine the requirement for candidate proteins. 3. The relationship between miRNA binding and the HCV replication cycle will be studied. Direct binding of miR-122, and of miR-196, which represses HCV gene expression, to HCV RNA will be detected over the course of the replication cycle using strepatividin affinity purification followed by quantitative RT-PCR. Sucrose gradients will be used to determine whether miR-122 is associated with actively translating polyribosomes.</gtr:technicalSummary><gtr:fund><gtr:end>2013-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>828533</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with David Evans, University of Warwick</gtr:description><gtr:id>A33F8D84-8D56-41C3-8B1B-45A469FA6F1D</gtr:id><gtr:impact>No joint publications.</gtr:impact><gtr:outcomeId>b95ff9c4b95ff9d8-1</gtr:outcomeId><gtr:partnerContribution>The Evans group led the research, with my group providing additional intellectual input and materials.</gtr:partnerContribution><gtr:piContribution>Named collaborator on MRC grant on 'Interplay of RNA structure, protein and miRNA binding in early replication events of hepatitis C virus', awarded July 2011.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Nick Proudfoot, University of Oxford</gtr:description><gtr:id>2F8F5512-A79A-4024-A146-4E6AB72983D2</gtr:id><gtr:impact>Dhir, Dhir, Proudfoot, Jopling. Manuscript published in Nature Structural and Molecular Biology, 2015</gtr:impact><gtr:outcomeId>5469e421bee669.64003148-1</gtr:outcomeId><gtr:partnerContribution>The Proudfoot lab carried out genome-wide analysis of transcription termination in miRNA genes. Intellectual input came from both groups and we worked together to write the manuscript detailing the results.</gtr:partnerContribution><gtr:piContribution>We initiated a collaboration with the Proudfoot lab to analyse the miR-122 gene. My lab carried out detailed characterisation of the gene.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Jane McKeating, University of Birmingham</gtr:description><gtr:id>0E03D90B-B044-40AE-81DF-429D5FE77B7B</gtr:id><gtr:impact>Fletcher et al, Gastroenterology 2012.
Lissauer et al, manuscript in preparation.</gtr:impact><gtr:outcomeId>5469e54016f034.27637176-1</gtr:outcomeId><gtr:partnerContribution>Analysis of hepatitis C virus infection in brain endothelial cell lines and differentiation.</gtr:partnerContribution><gtr:piContribution>Analysis of miR-122 in brain endothelial cell lines and of miR-122 regulation of hepatitis C virus translation in differentiation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation as part of University of Nottingham Summer School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>053DF3E0-FDC6-43CB-A465-74C1249FC4F3</gtr:id><gtr:impact>Around 30 sixth form students from disadvantaged backgrounds attended a summer school aiming to encourage them to apply to university. I gave a talk on RNA therapeutics to students interested in pharmacy, which sparked discussion during and afterwards.

It is difficult to quantify the impact of individual summer school presentations on students' university choices.</gtr:impact><gtr:outcomeId>5450cb47e5f9d7.43399570</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of editorial board, Biologist magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7EC4C14C-65BC-407D-B801-4B577A954134</gtr:id><gtr:impact>I attend editorial board meetings, make proposals for content, and review articles for general interest.

I have influenced the type of articles published in the Biologist with the aim of including interesting and stimulating content for the readership.</gtr:impact><gtr:outcomeId>5450ca7a0b13e7.78085306</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School of Pharmacy After School Science Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>15AA6A15-693C-45D4-B913-2F5619ABAE64</gtr:id><gtr:impact>I run two science outreach workshops a year in primary schools in deprived areas of Nottingham.

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-1273125737.22854780b975ac4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Publications in peer-reviewed journals.
Communication at scientific conferences.
Initiation of new research collaborations.
Communication to visiting sixth form students.</gtr:description><gtr:firstYearOfImpact>2009</gtr:firstYearOfImpact><gtr:id>80DCE0CA-04D4-43B1-A2A4-BD2030017779</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5450cebd9b3126.20025246</gtr:outcomeId><gtr:sector>Education</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have characterised the requirements for a specialised and important form of regulation of hepatitis C virus replication, by a liver-specific molecular known as microRNA-122. We have also developed new research directions to understand how levels of microRNA-122 are regulated.</gtr:description><gtr:exploitationPathways>MicroRNA-122 inhibitors are in phase 2 clinical trials as a therapy for hepatitis C virus. Understanding the details of this regulation may be important for refinement of this therapeutic strategy.</gtr:exploitationPathways><gtr:id>E92234F5-B5EA-4A60-9DFE-063F20F527DC</gtr:id><gtr:outcomeId>5450ce4e8b3ad8.75156826</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>76EA3ABC-FD61-427A-A961-B6E578B3105D</gtr:id><gtr:title>Regulation and biological function of the liver-specific miR-122.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38b1955d80d87ac29620de30dfaf51a9"><gtr:id>38b1955d80d87ac29620de30dfaf51a9</gtr:id><gtr:otherNames>Lewis AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_53cc037c037698675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01FEC35D-C1BF-4AF7-A533-F8743CCB85DC</gtr:id><gtr:title>Liver-specific microRNA-122: Biogenesis and function.</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/369e1bb773cc54f2b6092f9a828407ff"><gtr:id>369e1bb773cc54f2b6092f9a828407ff</gtr:id><gtr:otherNames>Jopling C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn><gtr:outcomeId>pm_53cc03dc03da4ff53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50BA2F9B-6BC4-45EE-950F-A2B6F5F331DB</gtr:id><gtr:title>Targeting viral infection by microRNA inhibition.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c40734d6ff9a89aff2216baa39fd88"><gtr:id>42c40734d6ff9a89aff2216baa39fd88</gtr:id><gtr:otherNames>Roberts AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_53cc033c033e537e0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA5B54A5-E51C-4EAD-A48D-15FD796A6215</gtr:id><gtr:title>Microprocessor mediates transcriptional termination of long noncoding RNA transcripts hosting microRNAs.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a5e4e61939a0ed41a320fc69d37dba3"><gtr:id>9a5e4e61939a0ed41a320fc69d37dba3</gtr:id><gtr:otherNames>Dhir A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>5675e04688a2f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6C2CA24-1757-405A-A2DF-EF7ABC1FA019</gtr:id><gtr:title>miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c40734d6ff9a89aff2216baa39fd88"><gtr:id>42c40734d6ff9a89aff2216baa39fd88</gtr:id><gtr:otherNames>Roberts AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_5435add5add649e8e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7887BD50-2F88-4B0C-8841-1E5B1892B8A7</gtr:id><gtr:title>The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c40734d6ff9a89aff2216baa39fd88"><gtr:id>42c40734d6ff9a89aff2216baa39fd88</gtr:id><gtr:otherNames>Roberts AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5450c74c4c2700.39564875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D12D449-A7C3-4F88-BEDE-17CE6D54044E</gtr:id><gtr:title>Regulation of hepatitis C virus by microRNA-122.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d93ead19689da684d30967068e43514"><gtr:id>5d93ead19689da684d30967068e43514</gtr:id><gtr:otherNames>Jopling CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_53cc030c0303ad8ea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1955E6F1-FF73-43C7-8586-766CD75AD73F</gtr:id><gtr:title>Targeting microRNA-122 to Treat Hepatitis C Virus Infection.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d93ead19689da684d30967068e43514"><gtr:id>5d93ead19689da684d30967068e43514</gtr:id><gtr:otherNames>Jopling CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_53cc03cc03c349ceb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F58AAE2-0B3B-4FC4-BFCA-BE6CBC83B680</gtr:id><gtr:title>The role of microRNAs in viral infection.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c40734d6ff9a89aff2216baa39fd88"><gtr:id>42c40734d6ff9a89aff2216baa39fd88</gtr:id><gtr:otherNames>Roberts AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>pm_53cc03bc03b775717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E91194E-E0AD-4756-8ABC-63FCA09FE7AB</gtr:id><gtr:title>Stop that nonsense!</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d93ead19689da684d30967068e43514"><gtr:id>5d93ead19689da684d30967068e43514</gtr:id><gtr:otherNames>Jopling CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5450c7aba2eab5.65965965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7386FE66-C6E6-4812-9B73-737FC4063062</gtr:id><gtr:title>Canonical initiation factor requirements of the Myc family of internal ribosome entry segments.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae5a933e7aa78460d5fe176c1565da7a"><gtr:id>ae5a933e7aa78460d5fe176c1565da7a</gtr:id><gtr:otherNames>Spriggs KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>pm_5435add5add46e654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F76215-A304-4E51-9E42-26538C7A17B6</gtr:id><gtr:title>Hepatitis C virus infects the endothelial cells of the blood-brain barrier.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e28545930847fbdf21015e10fbfd11d1"><gtr:id>e28545930847fbdf21015e10fbfd11d1</gtr:id><gtr:otherNames>Fletcher NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_5435add5add5460dd</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F02360X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>